Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study

Stefan P. Berger, Claudia Sommerer, Oliver Witzke, Helio Tedesco, Steve Chadban, Shamkant Mulgaonkar, Yasir Qazi, Johan W. De Fijter, Federico Oppenheimer, Josep M. Cruzado, Yoshihiko Watarai, Pablo Massari, Pietro Massari, Christophe Legendre, Franco Citterio, Mitchell Henry, Titte R. Srinivas, Flavio Vincenti, Maria Pilar Hernandez Gutierrez, Ana Maria MartiPeter Bernhardt, Julio Pascual

Research output: Contribution to journalArticle

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science